Clinical Trials Logo

Clinical Trial Summary

This is a multicenter randomized controlled study. By comparing patients with sinus bradycardia undergoing cardiac autonomic ganglion ablation and pacemaker therapy, and long-term follow-up to evaluate its safety and effectiveness after surgery, in order to evaluate the safety and effectiveness of cardiac autonomic ganglion ablation in the treatment of sinus bradycardia.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05021627
Study type Interventional
Source Shanghai Chest Hospital
Contact Xu Liu, MD
Phone +8613052320103
Email heartlx@sina.com
Status Not yet recruiting
Phase N/A
Start date September 1, 2021
Completion date August 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06276816 - Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
Enrolling by invitation NCT05903313 - A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Completed NCT02462941 - Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart Phase 1
Active, not recruiting NCT01200667 - uPHI: Wireless Body Area Network Core Technology N/A
Completed NCT02400983 - Real Life Automatic Atrial Capture Device Control N/A
Completed NCT00832260 - IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.